• Executive Summary
o Market Overview
• Market Landscape
o Market ecosystem
o Market characteristics
o Value chain analysis
• Market Sizing
o Market definition
o Market segment analysis
o Market size 2020
o Market outlook: Forecast for 2020 - 2025
• Five Forces Analysis
o Five forces summary
o Bargaining power of buyers
o Bargaining power of suppliers
o Threat of new entrants
o Threat of substitutes
o Threat of rivalry
o Market condition
• Market Segmentation by Technology
Market segments
Comparison by Technology
FISH - Market size and forecast 2020-2025
CISH - Market size and forecast 2020-2025
COVID-19 impact and recovery for technology segment
Market opportunity by Technology
• Market Segmentation by End-user
Market segments
Comparison by End user
Molecular diagnostic laboratories - Market size and forecast 2020-2025
Pharmaceutical and biotechnological companies - Market size and forecast 2020-2025
Others - Market size and forecast 2020-2025
COVID-19 impact and recovery for end-user segment
Market opportunity by End user
• Customer landscape
• Geographic Landscape
Geographic segmentation
Geographic comparison
North America - Market size and forecast 2020-2025
Europe - Market size and forecast 2020-2025
Asia - Market size and forecast 2020-2025
ROW - Market size and forecast 2020-2025
Key leading countries
Market opportunity by geography
Market drivers
Market challenges
Market trends
• Vendor Landscape
o Competitive scenario
o Vendor landscape
o Landscape disruption
o Industry risks
• Vendor Analysis
o Vendors covered
o Market positioning of vendors
o Abbott Laboratories
o Agilent Technologies Inc.
o Bio-Rad Laboratories Inc.
o Bio-Techne Corp.
o F. Hoffmann-La Roche Ltd.
o Merck KGaA
o PerkinElmer Inc.
o QIAGEN NV
o Thermo Fisher Scientific Inc.
• Appendix
o Scope of the report
o Currency conversion rates for US$
o Research methodology
o List of abbreviations
Exhibits
• 1: Key Finding 1
• 2: Key Finding 2
• 3: Key Finding 3
• 4: Key Finding 5
• 5: Key Finding 6
• 6: Key Finding 7
• 7: Key Finding 8
• 8: Key Finding 9
• 9: Parent market
• 10: Market characteristics
• 11: Offerings of vendors included in the market definition
• 12: Market segments
• 13: Global - Market size and forecast 2020 - 2025 ($ million)
• 14: Global market: Year-over-year growth 2020 - 2025 (%)
• 15: Five forces analysis 2020 & 2025
• 16: Bargaining power of buyers
• 17: Bargaining power of suppliers
• 18: Threat of new entrants
• 19: Threat of substitutes
• 20: Threat of rivalry
• 21: Market condition - Five forces 2020
• 22: Technology - Market share 2020-2025 (%)
• 23: Comparison by Technology
• 24: FISH - Market size and forecast 2020-2025 ($ million)
• 25: FISH - Year-over-year growth 2020-2025 (%)
• 26: CISH - Market size and forecast 2020-2025 ($ million)
• 27: CISH - Year-over-year growth 2020-2025 (%)
• 28: Market opportunity by Technology
• 29: End user - Market share 2020-2025 (%)
• 30: Comparison by End user
• 31: Molecular diagnostic laboratories - Market size and forecast 2020-2025 ($ million)
• 32: Molecular diagnostic laboratories - Year-over-year growth 2020-2025 (%)
• 33: Pharmaceutical and biotechnological companies - Market size and forecast 2020-2025 ($ million)
• 34: Pharmaceutical and biotechnological companies - Year-over-year growth 2020-2025 (%)
• 35: Others - Market size and forecast 2020-2025 ($ million)
• 36: Others - Year-over-year growth 2020-2025 (%)
• 37: Market opportunity by End user
• 38: Customer landscape
• 39: Market share by geography 2020-2025 (%)
• 40: Geographic comparison
• 41: North America - Market size and forecast 2020-2025 ($ million)
• 42: North America - Year-over-year growth 2020-2025 (%)
• 43: Europe - Market size and forecast 2020-2025 ($ million)
• 44: Europe - Year-over-year growth 2020-2025 (%)
• 45: Asia - Market size and forecast 2020-2025 ($ million)
• 46: Asia - Year-over-year growth 2020-2025 (%)
• 47: ROW - Market size and forecast 2020-2025 ($ million)
• 48: ROW - Year-over-year growth 2020-2025 (%)
• 49: Key leading countries
• 50: Market opportunity by geography ($ million)
• 51: Impact of drivers and challenges
• 52: Vendor landscape
• 53: Landscape disruption
• 54: Industry risks
• 55: Vendors covered
• 56: Market positioning of vendors
• 57: Abbott Laboratories - Overview
• 58: Abbott Laboratories - Business segments
• 59: Abbott Laboratories - Key offerings
• 60: Abbott Laboratories - Key customers
• 61: Abbott Laboratories - Segment focus
• 62: Agilent Technologies Inc. - Overview
• 63: Agilent Technologies Inc. - Business segments
• 64: Agilent Technologies Inc. - Key offerings
• 65: Agilent Technologies Inc. - Key customers
• 66: Agilent Technologies Inc. - Segment focus
• 67: Bio-Rad Laboratories Inc. - Overview
• 68: Bio-Rad Laboratories Inc. - Business segments
• 69: Bio-Rad Laboratories Inc. - Key offerings
• 70: Bio-Rad Laboratories Inc. - Key customers
• 71: Bio-Rad Laboratories Inc. - Segment focus
• 72: Bio-Techne Corp. - Overview
• 73: Bio-Techne Corp. - Business segments
• 74: Bio-Techne Corp. - Key offerings
• 75: Bio-Techne Corp. - Key customers
• 76: Bio-Techne Corp. - Segment focus
• 77: F. Hoffmann-La Roche Ltd. - Overview
• 78: F. Hoffmann-La Roche Ltd. - Business segments
• 79: F. Hoffmann-La Roche Ltd. - Key offerings
• 80: F. Hoffmann-La Roche Ltd. - Key customers
• 81: F. Hoffmann-La Roche Ltd. - Segment focus
• 82: Merck KGaA - Overview
• 83: Merck KGaA - Business segments
• 84: Merck KGaA - Key offerings
• 85: Merck KGaA - Key customers
• 86: Merck KGaA - Segment focus
• 87: NeoGenomics Laboratories, Inc. - Overview
• 88: NeoGenomics Laboratories, Inc. - Business segments
• 89: NeoGenomics Laboratories, Inc. - Key offerings
• 90: NeoGenomics Laboratories, Inc. - Key customers
• 91: NeoGenomics Laboratories, Inc. - Segment focus
• 92: PerkinElmer Inc. - Overview
• 93: PerkinElmer Inc. - Business segments
• 94: PerkinElmer Inc. - Key offerings
• 95: PerkinElmer Inc. - Key customers
• 96: PerkinElmer Inc. - Segment focus
• 97: QIAGEN NV - Overview
• 98: QIAGEN NV - Business segments
• 99: QIAGEN NV - Key offerings
• 100: QIAGEN NV - Key customers
• 101: QIAGEN NV - Segment focus
• 102: Thermo Fisher Scientific Inc. - Overview
• 103: Thermo Fisher Scientific Inc. - Business segments
• 104: Thermo Fisher Scientific Inc. - Key offerings
• 105: Thermo Fisher Scientific Inc. - Key customers
• 106: Thermo Fisher Scientific Inc. - Segment focus
• 107: Currency conversion rates for US$
• 108: Research Methodology
• 109: Validation techniques employed for market sizing
• 110: Information sources
• 111: List of abbreviations

Companies Mentioned
. Abbott Laboratories
. Agilent Technologies Inc.
. Bio-Rad Laboratories Inc.
. Bio-Techne Corp.
. F. Hoffmann-La Roche Ltd.
. Merck KGaA
. NeoGenomics Laboratories
. Inc.
. PerkinElmer Inc.
. QIAGEN NV
. Thermo Fisher Scientific Inc.